can glp 1 cause elevated liver enzymes GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response The Emerging Role of Glucagon-Like

Quality matters

Ocean acidification impairs olfactory discrimination and homing ability of a marine fish

Clinical trials have shown that individuals using Wegovy experienced an average weight loss of around 15% of their initial body weight over the course of the trial

The most robust clinical evidence arguably originates from the large cardiovascular outcomes trials (CVOTs) completed for most GLP-1 RAs, of which the latest showed a significant relative risk reduction (RRR) of 39% (HR) with once-weekly efpeglenatide on HF requiring hospitalisation, corroborating a meta-analysis which found a significant RRR across eight GLP-1 RA CVOTs of 11%